糖化血红蛋白水平与一级预防人群中腹主动脉瘤发病率的关系
基于英国生物银行326152名39至73岁参与者的前瞻性队列研究显示,糖化血红蛋白与腹主动脉瘤发病风险呈非线性倒U形关系,风险在5.82%处达峰后下降。与最低四分位组相比,Q2、Q3、Q4组腹主动脉瘤风险分别为1.14、1.11、1.27。年轻、低密度脂蛋白胆固醇升高及非糖尿病亚组风险升高更明显。
要点
- 糖化血红蛋白与腹主动脉瘤发病风险呈非线性倒U形关系,风险在5.82%处达峰。
- 与最低四分位组相比,Q4组腹主动脉瘤风险比为1.27(95%CI 1.12-1.44)。
- 年轻(<65岁)参与者Q4/Q1的腹主动脉瘤风险为2.38倍(95%CI 1.89-2.99)。
核心结论
- 糖化血红蛋白与腹主动脉瘤发病率呈双向关联,强调在腹主动脉瘤一级预防中优化血糖控制,尤其是年轻成人和高脂血症患者。
研究设计与样本
- 前瞻性队列研究,使用英国生物银行2006至2010年招募的326152名39至73岁参与者数据,通过国际疾病分类第10版编码从关联健康记录中识别腹主动脉瘤病例。
主要发现
- 糖化血红蛋白与腹主动脉瘤风险呈非线性倒U形关系,风险比在5.82%处达峰后下降。
- 与最低四分位组相比,Q2组风险比1.14(95%CI 1.01-1.29),Q3组1.11(95%CI 0.98-1.26),Q4组1.27(95%CI 1.12-1.44),趋势P值均<.05。
- 分层分析显示,年轻、低密度脂蛋白胆固醇升高及非糖尿病亚组风险升高更明显。
- 年轻(<65岁)参与者Q4/Q1的腹主动脉瘤风险为2.38倍(95%CI 1.89-2.99)。
- 敏感性分析证实关联稳健。
关键数值与推荐
- 与最低四分位组相比,Q2组风险比1.14(95%CI 1.01-1.29),Q3组1.11(95%CI 0.98-1.26),Q4组1.27(95%CI 1.12-1.44),趋势P值均<.05。
- 年轻(<65岁)参与者Q4/Q1的腹主动脉瘤风险为2.38倍(95%CI 1.89-2.99)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Abdominal aortic aneurysm (AAA) is a life-threatening condition characterized by the pathological dilation of the abdominal aorta. Diabetes mellitus is a well-established risk factor for cardiovascular diseases, yet its relationship with AAA remains debated. We aimed to identify longitudinal associations between glycated hemoglobin A1c (HbA1c) level and the risk of AAA development. METHODS: A prospective cohort study was conducted using UK Biobank data, encompassing 326,152 participants aged 39 to 73 years, recruited from 2006 to 2010. Participants provided biological samples and completed questionnaires. AAA cases was identified via International Classification of Diseases, 10th edition, codes from linked health records. HbA1c levels and other covariates were measured. Logistic and Cox regression models were used to assess the associations between HbA1c levels and AAA prevalence and incidence. Restricted cubic spline models were applied to examine dose-response relationships. Subgroup, interaction, and sensitivity analyses were also performed. RESULTS: The study revealed a nonlinear inverted U-shaped HbA1c-AAA risk relationship, with hazard ratios for AAA incidence peaking at 5.82% before declining. Compared with the lowest quartile of HbA1c levels, ascending quartiles showed progressively elevated AAA risks: Q2 = 1.14 (95% confidence interval [CI], 1.01-1.29), Q3 = 1.11 (95% CI, 0.98-1.26), Q4 = 1.27 (95% CI, 1.12-1.44; all P for trend < .05). Stratified analyses identified amplified risk escalation in younger age, elevated low-density lipoprotein cholesterol, and nondiabetic subgroups. Sensitivity analyses confirmed association robustness. Notably, younger participants (<65 years) exhibited 2.38-fold higher Q4/Q1 AAA risk (95% CI, 1.89-2.99). CONCLUSIONS: This study reveals a bidirectional HbA1c-AAA incidence association, underscoring the clinical imperative for optimized glycemic control in primary AAA prevention, particularly among younger adults and hyperlipidemic patients.
引用
- Wu Z, Li W, Hu J, et al. Glycated hemoglobin levels and abdominal aortic aneurysm incidence in primary prevention populations. J Vasc Surg. 2025. PMID: 40222571. doi:10.1016/j.jvs.2025.03.480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。